Grown Rogue International (GRUSF) Interest & Investment Income (2024 - 2026)
Grown Rogue International (GRUSF) posted quarterly Interest & Investment Income of $42187.0 for Q1 2026, up 17.39% year-over-year from $35937.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$1218.4 billion in Q4 2025.
Grown Rogue International (GRUSF) Interest & Investment Income (2024 - 2026) Analysis & Trends
Grown Rogue International's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $42187.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 17.39% year-over-year to $42187.0; the TTM figure through Mar 2026 stood at -$782.1 billion (down 198.97% YoY), while the FY2025 annual figure was $703068.0, up 100.5% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $42187.0, up from -$1218.4 billion in the prior quarter.
- The five-year high for Interest & Investment Income was $436.3 billion in Q3 2025, with the low at -$1218.4 billion in Q4 2025.
- The 3-year median for Interest & Investment Income is $99298.0 (2024), against an average of -$116.0 billion.
- Peak annual rise in Interest & Investment Income reached 142.54% in 2025, while the deepest fall reached 155.76% in 2025.
- Grown Rogue International's Interest & Investment Income stood at -$476.4 billion in 2024, then sank by 155.76% to -$1218.4 billion in 2025, then soared by 100.0% to $42187.0 in 2026.
- Business Quant data shows GRUSF's Interest & Investment Income at $42187.0 in Q1 2026, -$1218.4 billion in Q4 2025, and $436.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 114.97 Mn | 109.89 Mn | 5.37 Mn | 104,356.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104,356.00 |
| Mar 31, 2026 | 42,187.00 |
| Dec 31, 2025 | -1,218.45 Bn |
| Sep 30, 2025 | 436.32 Bn |
| Jun 30, 2025 | 393,669.00 |
| Mar 31, 2025 | 35,937.00 |
| Dec 31, 2024 | -476.39 Bn |
| Sep 30, 2024 | 214.79 Bn |
| Jun 30, 2024 | 162,312.00 |
| Mar 31, 2024 | 99,298.00 |